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ABSTRACT The use of hyperspectral imaging for medical applications is becoming more common in recent
years. One of the main obstacles that researchers find when developing hyperspectral algorithms for medical
applications is the lack of specific, publicly available, and hyperspectral medical data. The work described in
this paper was developed within the framework of the European project HELICoiD (HypErspectraL Imaging
Cancer Detection), which had as a main goal the application of hyperspectral imaging to the delineation
of brain tumors in real-time during neurosurgical operations. In this paper, the methodology followed to
generate the first hyperspectral database of in-vivo human brain tissues is presented. Data was acquired
employing a customized hyperspectral acquisition system capable of capturing information in the Visual
and Near InfraRed (VNIR) range from 400 to 1000 nm. Repeatability was assessed for the cases where
two images of the same scene were captured consecutively. The analysis reveals that the system works more
efficiently in the spectral range between 450 and 900 nm. A total of 36 hyperspectral images from 22 different
patients were obtained. From these data, more than 300 000 spectral signatures were labeled employing a
semi-automatic methodology based on the spectral angle mapper algorithm. Four different classes were
defined: normal tissue, tumor tissue, blood vessel, and background elements. All the hyperspectral data has
been made available in a public repository.
INDEX TERMS Hyperspectral imaging, cancer detection, biomedical imaging, medical diagnostic imaging,
image databases.
The associate editor coordinating the review of this manuscript and
approving it for publication was Bora Onat.
I. INTRODUCTION
Hyperspectral imaging (HSI) is a non-contact, non-ionizing
and non-invasive sensing technique suitable for medical
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applications [1]. HSI consists in collecting and processing
information across the electromagnetic spectrum, beyond the
human eye capabilities that cover the range from 390 to
700 nm [2]. HSI increases the amount of information acquired
from a certain scene, compared with a conventional RGB
(Red, Green and Blue) image or a multi-spectral image,
by capturing more data in a large number of contiguous and
narrow spectral bands over a wide spectral range. Depending
on the type of sensor employed, hyperspectral (HS) cameras
will cover different spectral ranges. CCD (Charge-Coupled
Device) sensors cover the VNIR (Visible and Near-InfraRed)
range from 400 to 1000 nm, while InGaAs (Indium Gallium
Arsenide) sensors are able to capture HS images in the NIR
(Near-InfraRed) range, between 900 and 1700 nm. Other
types of sensors can reach larger spectral ranges. For exam-
ple, MCT (Mercury Cadmium Telluride) sensors are able to
acquire HS images in the SWIR (Short-Wavelength InfraRed)
range, from 1000 to 2500 nm [3].
HSI has been employed for many years in remote
sensing applications [4]. However, more recently, HSI is
progressively being used in other fields, such as drug anal-
ysis [5], [6], food quality inspection [7]–[10] or defense
and security [11], [12] among many others. Furthermore,
HSI is an emerging image modality in the medical field,
offering promising results for the detection and diagnosis
of different types of diseases [13]. In particular, there are
several studies considering cancer analysis and diagnosis.
As cancer involves a change in cellular pathology associ-
ated with different chemical signature [14], it should be
detected as a change in the HS signature of the tissue. HSI
has been used to detect different types of cancer, such us
cervix [15], breast [16]–[18], colon [19]–[22], gastrointesti-
nal [23], skin [24], [25], prostate [26], [27], oral tissue [28]
and tongue [29]–[31] cancers. Regarding HSI to assist brain
surgery, the work performed by this research group in [32]
is the first study reported to the best of authors’ knowledge.
One of the major benefits of this technology is that it can
be used as a guidance tool during brain tumor resections.
Unlike other tumors, brain tumor infiltrates the surrounding
normal brain tissue and thus their borders are indistinct and
extremely difficult to identify to the surgeon’s naked eye.
The surrounding normal brain tissue is critical and there is
no redundancy, as in many other organs where the tumor
is commonly resected together with an ample surrounding
block of normal tissue. This is not possible in the brain, where
it is essential to accurately identify themargins of the tumor to
resect as less healthy tissue as possible [33]. As a result, HSI
can be applied for a precise localization of malignant tumors
during surgical procedures [32], [34].
Currently, several imaging modalities are employed as
guidance tools to assist the tumor resection in neurosurgical
operations. However, these systems have many limita-
tions. Intraoperative neuronavigation systems uses preop-
erative image information, such as magnetic resonance
imaging (MRI) or computed tomography (CT), to monitor
the surgery in real-time. Nevertheless, the tumor boundary
delimitation is not accurate enough due to the brain shift
phenomenon [35]–[38]. On the contrary, intraoperative MRI
solves the brain shift problem accurately monitoring the tis-
sue resection intraoperatively. However, this method requires
a specific operating theater with MRI-compatible equipment
and increase the duration of the surgery [39]. Moreover,
the refreshing rate of intraoperative MRI is much lower
than the refreshing rate of HSI. On the other hand, ultra-
sound (US) is inexpensive, real-time, unaffected by brain
shift, and for most gliomas it can identify the contrast-
enhancing portion seen on MRI, reliably identifying tumor
margins [40], [41]. However, it has been reported that the use
of intraoperative US can cause the resection of histologically-
normal parenchyma [42]. Furthermore, intraoperative US
leaves borders difficult to demarcate [43] and it is also
time-consuming and operator-dependent [41], requiring large
experience by the user to interpret the ultrasound images.
It also lacks image resolution [44]. Finally, the main competi-
tors of HSI for brain tumor detection are the systems based
on fluorescent tumor markers, such as 5-aminolevulinic acid
(5-ALA). These systems are capable of providing intra-
operative tumor margins detection with high accuracy and
refreshing rate. However, this technique may produce impor-
tant side effects for the patient, being not recommended
for pediatric cases [45]. Furthermore, it can only be used
to detect high-grade tumors [46]. For these reasons, HSI
could lead to a potential solution to these problems, being a
non-contact and label-free technique totally harmless for the
patient.
This paper presents the first in-vivoHS human brain image
database, mainly generated to study its ability to delineate
and identify brain tumors during surgical operations using
this non-invasive and non-ionizing image modality. This
database has been generated within the HELICoiD (HypEr-
spectraL Imaging Cancer Detection) project. HELICoiD was
an European collaborative project funded by the Research
Executive Agency (REA), through the Future and Emerging
Technologies (FET-Open) Programme, under the 7th Frame-
work Programme of the European Union. The project was a
collaboration between four universities, three industrial part-
ners and two hospitals, where the main goal was to employ
HSI to develop a methodology to discriminate between tumor
and normal brain tissue in surgical-time during surgical pro-
cedures by employing machine learning techniques [47]. The
integration of HSI in an intraoperative image guided surgery
system could have a direct impact on the patient outcomes.
Potential benefits would include allowing confirmation of
complete resection during the surgical procedures, avoiding
complications due to the brain shift phenomenon, and pro-
viding confidence that the goals of the surgery have been
successfully achieved.
II. THE INTRA-OPERATIVE HS ACQUISITION SYSTEM
A customized intraoperative HS acquisition system [32],
[48], [49], developed within the HELICoiD research project,
was used to generate the in-vivo HS human brain image
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FIGURE 1. In-vivo HS brain surface acquisition procedure. (a) Hyperspectral acquisition system being used during the acquisition process in a
neurosurgical operation. (b) Hyperspectral images acquired with the acquisition system at different wavelengths from a patient affected by a
glioblastoma tumor. (c) HSI data cube. (d) RGB image generated from the HS cube with the tumor tissue marker (left) and the normal tissue
marker (right) placed on the brain surface. (e) and (f) Histopathological images of the tumor tissue sample (glioblastoma) and normal tissue
sample respectively. (g) Gold standard map where certain pixels have been labeled in four different classes: normal brain tissue (green), tumor
tissue (red), blood vessel (blue) and background (black). (h) Average and standard deviation (Std) of the pre-processed spectral signatures of
tumor tissue, normal tissue and blood vessel labeled pixels, represented in red, green and blue color respectively.
database. Fig. 1.a shows the intraoperative HS acquisition
system being used during a neurosurgical operation at the
University Hospital Doctor Negrin of Las Palmas de Gran
Canaria, Spain. A Hyperspecr VNIR A-Series camera
(HeadWall Photonics Inc., Fitchburg, MA, USA) composes
the acquisition system. The HS camera is based on pushb-
room technique and covers the spectral range from 400 to
1000 nm, with a spectral resolution of 2–3 nm, being able
to capture 826 spectral bands and 1004 spatial pixels per line
(Fig. 1.b and c). The camera uses a silicon CCD detector array
with a minimum frame rate of 90 fps (frames per second).
In this context, a frame refers to a line of 1004 pixels and
826 spectral bands. A Xenoplan 1.4 lens (Schneider Optics,
Hauppauge, NY, USA) with 22.5 mm of focal length and a
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broadband coating for the spectral range between 400 and
1000 nm is coupled to the camera.
The camera is fixed to a scanning platform composed by
a stepper motor coupled to a spindle capable of covering an
effective capturing area of 230 mm. The scanning platform
is required to obtain the second spatial dimension of the HS
cube, since the pushbroom camera only captures a single spa-
tial dimension. Additionally, the acquisition system integrates
an illumination system based on a QTH (Quartz-Tungsten-
Halogen) lamp connected to a cold light emitter through fiber
optic cable that cover the spectral range between 400 and
2200 nm. This illumination system allows providing cold
illumination over the brain surface in order to avoid the high
temperature produced by the QTH lamp.
III. IN-VIVO HS HUMAN BRAIN DATABASE
A. PARTICIPANTS
All adult patients (18 years old and above) undergoing cran-
iotomy for resection of intra-axial brain tumors at both par-
ticipating sites were approached for inclusion in the study.
The data acquisition was performed in two different cam-
paigns that covered the period comprised fromMarch 2015 to
June 2016. The University Hospital of Southampton (UHS),
UK, and the University Hospital Doctor Negrin (UHDRN)
of Las Palmas de Gran Canaria, Spain, were the participant
sites. Patients with both primary and secondary tumors were
included in the database. Patients that underwent resection
of meningioma, where the dura was resected, were also
included whenever it was possible to properly capture the
exposed normal brain. The study protocol and consent pro-
cedures were approved by the Comité Ético de Investigación
Clínica-Comité de Ética en la Investigación (CEIC/CEI)
for the University Hospital Doctor Negrin and the National
Research Ethics Service (NRES) Committee South Central
- Oxford C for the University Hospital of Southampton.
Written informed consent was obtained from all the subjects.
B. HS IMAGE ACQUISITION PROCEDURE
This section provides an overview of the procedure carried
out to obtain the HS in-vivo images from the human brain
surface that were stored in the database (Fig. 1). Furthermore,
the process of labeling the samples as tumor tissue or normal
brain tissue is described. The procedure followed to acquire
and label the spectral signatures of the in-vivo brain surface
is based on five steps: patient preparation, HS image acquisi-
tion, tissue resection, neuropathology evaluation and sample
labeling.
1) PATIENT PREPARATION
Before the operation, a CT (Computed Tomography) and
MRI (Magnetic Resonance Imaging) of the patient’s head
compatible with IGS (Image Guide Stereotactic) are per-
formed. These images are uploaded onto the IGS system
before the operation started. Then, the patient is placed in a
supine position, under general anesthesia and is registered to
FIGURE 2. MRI markers registration. (a) IGS system pointer over the
tumor marker located on the exposed brain surface. (b) IGS system
screen snapshot with the coordinates of the tumor marker in the MRI.
the IGS system. A scalp incision is made and a burr hole/s
drill using a high-speed drill. A craniotome is then inserted
into the burr hole/s and a bone flap cut out (craniotomy). The
dura is then cut with a knife (durotomy) to expose the brain
surface.
2) HS IMAGE ACQUISITION
HS images are captured after durotomy, before the arachnoid
and pia are breached in cases where the tumor extended to
the brain surface. Sterilized rubber ring markers were placed
to identify the position of the tumor and the normal brain
(Fig. 1.d), employing the IGS system pointer to establish the
exact location of the markers over the brain. This pointer
provides information about the position of the markers with
respect to an MRI or CT, which are performed prior to the
surgical procedure.
Fig. 2.a and b show the use of the IGS system pointer
to identify the position of the markers over the brain on
MRI. Normal brain markers are also placed by the oper-
ating surgeon based on visual appearance and anatomical
relationship to sulci and gyri, apart from the IGS feedback.
Normal markers are placed where the operating surgeon is
quite confident that the brain tissue is normal. The operator
of the HS acquisition system then captures the HS image
of the exposed brain surface. The image size established by
the operator for the image acquisition should be oversized to
avoid the inherentmovement of the systemwhen the scanning
platform is starting the capturing process. This will ensure the
spatial coherence of the center of the image where the region
of interest (the exposed brain surface) is located. In addi-
tion, the operator must avoid unintentional movements of
the acquisition system during image acquisition for the same
reason. In case of an unexpected movement, the capturing
process must be repeated.
3) TISSUE RESECTION
After the first HS image capture, the HS acquisition system is
moved out from the surgical area and the operating surgeons
undertake the tumor resection. Surgeons take samples of
the tissue located inside the tumor marker and place it in a
sterile container. An identification (ID) number is assigned to
the container with the corresponding marker number. These
samples are sent to the neuropathology laboratory and the
results are used for the gold standard dataset generation. The
IDs assigned to the markers serve as guidance in the labeling
process.
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When possible, a second set of images is capturedwhile the
tumor is being resected. When there is macroscopically nor-
mal brain and tumor exposed and when the operating surgeon
feels that it is safe to temporarily hold surgery, the surgeon
ensures perfect hemostasis and washes the field thoroughly
with warm saline to wash away any residual blood while
ensuring no significant temperature change (and resultant
blood flow change). Next, the field is sucked dry by the
application of a cottonoid to the parenchyma and applying
suction to this. Then, the operating surgeon identifies themost
suitable location to capture the images.
4) NEUROPATHOLOGY EVALUATION
The resected tissue is sent to the neuropathology laboratory
where it is formalin fixed and undergoes standard H&E
(Hematoxylin and Eosin) staining and any further required
staining to establish a definitive histopathological diagnosis.
Neuropathologists perform the histopathological diagnosis,
employing techniques used in the routine clinical practice.
Samples are classified as tumor or normal brain. Furthermore,
tumor samples are subdivided into tumor type and grade.
Fig. 1.e and f show an example of a histopathological image
of a glioblastoma and normal brain tissues, respectively.
5) SAMPLE LABELING
In the last step, by using the information provided by the neu-
ropathologists and the knowledge of the operating surgeons,
several pixels are labeled taking as a reference the spectral
signatures of certain pixels inside the markers and outside
the markers for the non-tumor classes. The total number of
reference pixels selected per image is detailed in Table 1.
After the labeling process (explained in section IV), a gold
standard map of each image is obtained (Fig. 1.g). Pixels that
present specular reflections produced by the non-uniformity
of the brain surface are avoided.
The gold standard maps are composed of four classes:
tumor tissue (red color), normal brain tissue (green color),
blood vessels (blue color) and background (black color).
Based on the indications given by the pathologist, the even-
tually possible normal inflamed labeled tissue has been
included in the normal class. The background class comprises
any other tissues, materials or substances that can be present
in the surgical scene and are not relevant for the tumor resec-
tion. Blood vessels and background pixels are labeled by the
surgeon with the naked eye. White pixels in the gold standard
map are the pixels that are not labelled.
C. DATA PRE-PROCESSING
The HS data obtained are pre-processed following the pre-
processing chain presented in [32]. Four main steps compose
this chain: image calibration, noise filtering, band averaging
and pixel normalization.
After image acquisition, the HS raw data are calibrated
using white and dark reference images. The white refer-
ence image is captured from a Spectralonr tile (SphereOp-
tics GmbH, Herrsching, Germany) in the same illumination
conditions in which the images were captured. This mate-
rial reflects the 99% of the incoming radiation in the range
between 400 and 1000 nm. The dark reference image is
obtained by keeping the camera shutter closed. This cal-
ibration procedure is performed to avoid the problems of
the spectral non-uniformity of the illumination device and
the dark currents produced by the camera sensor, avoiding
the influence of the external illumination conditions. Next,
due to the high noise generated by the camera sensor, a set of
steps with the goal of removing this noise from the spectral
signatures and to reduce the number of bands of the samples
without losing relevant spectral information are applied.
Fig. 1.h shows an example of the average and stan-
dard deviations of the pre-processed spectral signatures of a
glioblastoma and normal brain tissues as well as blood vessel
labeled pixels, represented in red, green and blue respectively.
IV. HS GOLD STANDARD DATABASE
In this application where human living patients are involved,
it is not possible to achieve a complete gold reference map
of the captured image with 100% of certainty that the pixel
represents the established class. To achieve that, a pathologist
should analyze the entire brain tissue exposed in the image
and this is obviously not possible due to ethical reasons,
since in this case the neurosurgeon should resect all the tissue
exposed in the brain surface (including tumor and normal),
causing serious problems to the patient health. In other fields
such as remote sensing or even in the medical field but using
ex-vivo or in-vitro tissue the complete gold reference genera-
tion is a relatively easy task, but using in-vivo human samples
(and especially in the brain) this task is highly complex and
nearly impossible nowadays.
In this section, we propose a methodology to achieve a
partial gold standard map of the HS image of the in-vivo
brain surface based on four key factors: 1) The pathologi-
cal analysis of a tumor sample to confirm the tumor tissue
location and diagnosis; 2) The association of the HS cap-
tured image with the intraoperative neuronavigation system
to locate the approximated area of the tumor; 3) The expe-
rience and knowledge of the neurosurgeon to identify the
normal, hypervascularized and background classes and also
the approximated area of the tumor tissue following the indi-
cations of the neuronavigation system and the pathological
diagnosis; 4) The spectral properties of each tissue class to
find the most similar pixels with respect to a reference pixel
selected by the operating surgeon by using a labelling tool
specifically developed to this end.
Commonly, manual gold standard dataset definition is usu-
ally done by visual inspection of the scene and the succes-
sive labeling of each sample. This labeling methodology can
produce errors in the final gold standard map (especially in
this application), since it is possible to label by mistake pixels
with different spectral information in the same class due to the
manual procedure. Therefore, in order to build a gold standard
as reliable as possible, a labelling tool based on the Spectral
Angle Mapper (SAM) algorithm [50] was developed for this
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FIGURE 3. Semi-automatic labeling process flowchart. (a) Pre-Processed HS cube. (b) Synthetic RGB
image extracted from the HS cube. (c) SAM mask over the synthetic RGB image. (d) Final gold standard
map.
application to generate a robust and efficient gold standard
dataset.
An interactive graphical user interface was designed using
the Matlabr GUIDE application (The MathWorks Inc., Nat-
ick, MA, USA). In the first step of the labeling process,
the specialist (the operating surgeon) selects the coordinates
of a reference pixel in a synthetic RGB image generated
from the HS cube. The synthetic RGB image is generated
by extracting three specific spectral bands from the HS cube
that correspond with red (708.97 nm), green (539.44 nm),
and blue (479.06 nm) colors. The reference pixel can be
selected at the site where the biopsy was performed (where
the marker is located) or at a site far enough from the
tumor margins where the surgeon can be quite confident
that the tissue is abnormal (in the case of tumor labeling).
The tissue presented inside the tumor markers was sent to
pathology for a precise diagnosis of the tumor. In the case
of normal tissue, hypervascularized tissue and background
classes, the labeling is performed by selecting a reference
pixel by the naked eye based on the surgeon’s knowledge
and experience. Then, the spectral angle between the selected
pixel and the other pixels of the HS cube is calculated.
In this moment, the operating surgeon manually establishes a
threshold to match the physiological features of the selected
tissue. This means that the most spectrally similar pixels with
respect to the selected reference pixel are highlighted using a
binary mask. This masked image contains only pixels with
a spectral angle lower than the established threshold with
respect to the reference pixel. Once the user concludes that
only the pixels belonging to one class have been highlighted,
the selected pixels are assigned to that class. Neurosurgeons
were instructed to select only few sets of very reliable pixels
instead of a wider set of uncertain pixels.
This labeling framework provides two main advantages to
generate the gold standard maps. On the one hand, when the
specialist selects a reference pixel, it is possible to ensure that
the selected pixel indeed belongs to a certain class by looking
at the synthetic RGB masked image, where the pixels with
lower spectral angle with respect to the reference pixel are
shown. On the other hand, the process of manually selecting
pixels from a HS cube for each class is a time-consuming
task, so this semi-automatic method allows generating the
gold standard in an efficient way.
Fig. 3 presents the block diagram of this procedure and the
information available at each stage of the labeling process.
Fig. 3.a represents the pre-processed HS cube that is the input
to the labeling chain while Fig. 3.b shows the synthetic RGB
representation of the HS cube, where the reference pixels are
selected. Fig. 3.c illustrates the synthetic RGBmasked image
after applying the SAMalgorithm between the reference pixel
and the other pixels of the HS cube with a certain fixed
threshold. In addition, in this image is possible to see the
area selected by the specialist, which will be labeled in a
certain class. Finally, Fig. 3.d shows the final gold standard
map generated after the labeling procedure, where the labeled
pixels that belong to tumor tissue, normal brain tissue, blood
vessels and background are identified with red, green, blue
and black colors respectively. EachHS image of the generated
database has its respective gold standard map. In addition,
Fig. 4 represents the threshold values established for each
reference pixel in each image for each class. As it can be
seen, in average, the threshold values for the normal, tumor
and hypervascularized classes are lower than 10%. However,
in the background class there is a higher variability due to
the different materials and tissues that can be included in this
class.
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FIGURE 4. Threshold values selected for each reference pixel in each image for each class. (a) Normal class. (b) Tumor class. (c) Hypervascularized class.
(d) Background class.
V. REPEATABILITY ANALYSIS OF THE HS ACQUISITION
SYSTEM
The developed HS acquisition system was tested by per-
forming two different types of repeatability experiments.
The goal of this study was to evaluate the possible sources
of systematic errors in the acquisition system and to ver-
ify the repeatability of the spectra when images of the
same scene were obtained. This section summarizes the
procedure and the results acquired in the spatial and
spectral repeatability tests performed using three different
pairs of HS cubes obtained with the previously introduced
system.
A. REPEATABILITY DATASET
Three different scenes were captured twice and consecutively
in the same environmental conditions to perform the repeata-
bility experiments. In total, three pairs of HS cubes were
obtained: a white reference tile employed to calibrate the
system, a chessboard pattern and a book cover fragment with
high spatial and spectral entropy (image with high amount of
information). Fig. 5 shows the reconstructed RGB represen-
tations of these HS cubes. The white reference tile (Fig. 5.a)
and the chessboard pattern (Fig. 5.c) are simple and geomet-
rically uniform. These images were suitable to identify any
relevant difference or geometric distortion between each pair
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FIGURE 5. HS images of the repeatability dataset and their
correspondent scatterplot of the voxel values of an example section of
200× 200 pixels obtained from two HS cubes of the same scene: (a) and
(b) White reference tile; (c) and (d) Chessboard pattern; (e) and (f) Book
cover fragment.
of images. The book cover fragment (Fig. 5.e) was selected
due to the multiple internal reflections and changes in the
reflected light path because of intermediate refractions.
B. REPEATABILITY METRICS
The motivation for performing these experiments was to
quantify the repeatability of the acquisition system, which
enables the analyst to assess the a priori feasibility of per-
forming ‘‘correct’’ regression or classification model for a
given target. If the repeatability error is high across all the
spectral bands, any statistical modeling will be prone to spu-
rious results [51].
In Fig. 5, the scatterplots of an example section of
200×200 pixels obtained from the two HS cubes of the same
target are shown. The selected areas have been surrounded
using a red box. In the scatterplot, the voxel values of each
HS cube section pair are represented (more than 33 million
of voxel pairs). Ideally, this scatterplot should be a straight
line, indicating that all the correspondent voxel value pairs
contain the same exact information. In this case, the repeata-
bility of the system will be optimal. However, in the real
world, the scatterplot will be expanded depending on both the
repeatability qualities of the system and the complexity and
contrast of the captured scene. In this sense, Fig. 5.b show
the scatterplot of the white reference tile (a homogeneous
scene), where it is possible to observe that the system offers
a low variability in the voxel values from both HS cubes.
Nevertheless, when the scene contrast increases (Fig. 5.c),
the scatterplot is highly scattered (Fig. 5.d). A small vari-
ation in the scene position can produce a high variation in
the voxel values due to the high contrast of the chessboard
pattern borders. In the scatterplot of the book cover fragment
(Fig. 5.f), the expansion is lower than the chessboard pattern
due to the scene contrast is lower. This last one is a more
realistic example.
The measures and protocols proposed in [51] were
employed for these experiments. In [51], the spatial repeata-
bilityis defined as the differences between the pixel values of
the respective spectral layers in two HS cubes from the same
scene, while the spectral repeatability is defined as the differ-
ences between the spectral curves of their respective voxels
(value of a pixel in a certain wavelength). The repeatability
error (RE) is computed as the root mean square (rms) of the
differences between two vectors (x, y) is calculated. The ideal
value of RE is zero, but in practice RE is always higher than
zero. In this sense, this metric can be modified to represent
the noise-to-signal ratio (N/S) or its inverse, signal-to-noise
ratio (S/N), being zero and infinite their ideal values. These
metrics are defined in (1) and (2), respectively. Furthermore,
another metric employed to measure the repeatability of the
system is the absolute relative difference percentage (RD)
that is defined in (3). In this metric, the relation between the
absolute difference and the mean values of the two vectors
is computed. In this case, the lower RD, the better that the
repeatability of the system will be. S/N and RD metrics were
employed to measure the spectral and spatial repeatability
of the system by using plot charts, while N/S and RD were
employed to represent graphically the spectral repeatability
in a certain band.
N/S = rms(x − y)
rms(x ∪ y) (1)
S/N = rms(x ∪ y)
rms(x − y) (2)
RD(%) = abs(x − y) ∗ 100
[mean (x)+ mean (y)] /2 (3)
C. SPECTRAL REPEATABILITY
Spectral repeatability considers a spatial-slice as a vector by
fixing the wavelengths (λ) and calculating the previously
defined metrics. Several HS cubes were created using a
pushbroom technique, whereby the complete HS image of
the target was generated by joining multiple contiguous non-
overlapped image strips (line scans). During each line scan,
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FIGURE 6. Pushbroom technique block diagram example.
the CCD sensor acquired a multi-layer slice of the HS cube,
where each layer belonged to a predetermined spectral band.
Each column of the CCD sensor acquired the spectrum of one
pixel and each row (CCD bins rows) contained one spectral
band of the HS cube slice. In this sense, it is possible to
distinguish between spectral repeatability along the line scans
and along the CCD bins rows of the HS cube. Fig. 6 shows an
example of how the HS cube is generated using a pushbroom
technique.
The spectral repeatability experiments allow measuring
possible errors produced due to the vibrations of the acquisi-
tion system, the interline scanning errors or errors produced
due to differential responses of the CCD bins. These are the
most common sources of errors in pushbroom HS systems.
Fig. 7 shows the spectral repeatability results of S/N and
RD along the line scans for the three different pairs of HS
images. These curves assess the stability of the repeatability
indexes from line scan to line scan, as well as detecting the
location of possible outlier voxels. As it can be seen in the
results, the average of the S/N index decreases when the
complexity of the captured scene increases. In the case of
the RDmean metric, the mean value of each line scan was
calculated and it increases when the complexity of the image
increases. Fig. 7.a shows the results obtained for the white
reference image, where is possible to observe that when the
system captures a spatially homogeneous image, the spectral
repeatability along the line scans is stable and minimal. How-
ever, in the case of the results obtained for the chessboard
pattern image, the peaks obtained in the plot reveal that the
repeatability errors are mainly produced in the borders of the
image pattern (Fig. 7.b).
In the case of the book cover image (Fig. 7.c) the error is
spread in all the line scans and it is mainly produced due to the
reflections of the light on the surface and the movement of the
system. The worst S/N value is obtained for the chessboard
pattern image, which can be caused by the abrupt changes in
the pattern due to the motion of the pushbroom sensor across
the different scanlines. However, the average RDmean metric
is lower than the value obtained for the book cover image.
Fig. 8 presents the spectral repeatability results along the
CCD bins for the three pairs of HS images. The dome-
shaped curves obtained in the S/N and RDmean metrics of
FIGURE 7. Spectral repeatability indexes in line scans of the three
different HS cube pairs: (a) White reference tile; (b) Chessboard pattern;
(c) Book cover fragment.
the white reference image (Fig. 8.a) show that the spectral
repeatability was better in the center of the CCD array than in
the borders. This is mainly caused due to optical aberrations
produced at the ends of the sensor and to inhomogeneous
illumination across the X pushbroom scan direction. Fig. 8.b
and c show the results obtained for the chessboard pattern
and the book cover, respectively. In this case, the worst S/N
value is obtained for the chessboard pattern image. However,
the average RDmean metric is lower than the one obtained for
the book cover image.
Finally, Fig. 9 shows the spatial representation of the spec-
tral repeatability indexes of N/S and RDmean of the white
reference tile (Fig. 9.a), the chessboard pattern (Fig. 9.b) and
the book cover fragment (Fig. 9.c) HS cube pairs at a certain
wavelength (λ = 690.78 nm). This λ value was selected as an
example to represent the error in a centered wavelength of the
spectrum. The repeatability indexes are depicted in false color
images. The scales of the false colors on the right side of each
image determine the values and ranges of the corresponding
repeatability index.
In these false color images, it is possible to identify directly
by visual inspection the regions of the images where the
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FIGURE 8. Spectral repeatability indexes in CCD bins of the three
different HS cube pairs: (a) White reference tile; (b) Chessboard pattern;
(c) Book cover fragment.
repeatability of the system is extremely high or low. In this
sense, the repeatability is quite low in the areas of the images
with higher spatial entropy. These high-entropy areas cannot
be accurately reproduced due to the fine resolution of the
spatial scanning required to obtain the HS cube. For example,
in the chessboard pattern image (Fig. 9.b) the boundaries of
the pattern have a low repeatability while in the book cover
image (Fig. 9.c) low repeatability areas are also in the borders
of the letters and the drawing as well as in the relief produced
by plasticizing the book cover. The spectral repeatability is a
function of the ambient light and the nature of the materials
presented in the scene [51].
D. SPATIAL REPEATABILITY
The spatial repeatability measures the differences between
pixel values at a certain wavelength in HS cubes of the same
scene. Fig. 10 shows the S/N and RDmean metrics for each
one of the HS cube pairs to measure the spatial repeatability
of the HS acquisition system. As it can be seen in the results,
the spatial repeatability of the system was better in the center
wavelengths and worse towards the first and the last spectral
FIGURE 9. Spatial representation of the spectral repeatability indexes of
N/S and RDmean of the three different HS cube pairs at a certain
wavelength (λ = 690.78 nm): (a) White reference tile; (b) Chessboard
pattern; (c) Book cover fragment.
bands. This is produced because in the shorter wavelengths
the photons have higher energy than in the longer ones.
Consequently, they are absorbed closely to the CCD sensor
surface and not by the active part of the detector [51]. The
oscillations presented in the S/N plot of the book cover
fragment (Fig. 10.c) are produced due to the presence of
multiple materials that have low and high reflectance values
in different wavelengths.
Taking into account the results of these experiments,
the optimal spectral range where the system can operate
efficiently is comprised between 450 and 900 nm approx-
imately. For this reason, during the pre-processing of the
HS cubes, the reflectance values outside of this range were
avoided.
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FIGURE 10. Spatial repeatability indexes of the three different HS cube
pairs: (a) White reference tile; (b) Chessboard pattern; (c) Book cover
fragment.
VI. DATABASE SUMMARY
The gold standard dataset generated using the previously pre-
sented labeling methodology is composed by 36 in-vivo brain
surface images from 22 different patients. In this images,
tumor and normal tissue were labeled (when possible) as well
as the blood vessels and other tissues, materials or substances
that can be presented in the surgical scene and are not relevant
for the surgical resection procedure (called hereafter back-
ground). Fig. 11 shows the average and standard deviation
of each type of tissue presented in the labeled dataset across
all the patients, differentiating between the tumor types. This
dataset includes both primary (grade IV glioblastoma and
grade III and II anaplastic oligondendrogliomas) and sec-
ondary (lung and breast) tumors. Fig. 12 shows the RGB
representations of the HS cubes that compose the in-vivo HS
human brain image database, where the approximate tumor
area is surrounded by a yellow line in order to identify the rub-
ber ring marker that corresponds to the pathological analysis
performed over the tumor tissue. The codes above each image
are the Patient ID and Image ID shown in Table 1, which
summarizes the total number of images available in this
FIGURE 11. Average and standard deviation (Std) across all the patients
of the different types of spectral signatures in the labeled database:
(a) Normal tissue; (b) Blood vessels; (c) GBM tumor; (d) Anaplastic
oligodendroglioma tumor; (e) Secondary breast tumor; (f) Secondary lung
tumor.
database, its characteristics and the pathological diagnosis of
each image. Furthermore, the total number of labeled pixels
for each class and image are detailed. As it can be seen, some
images were diagnosed as a certain type of tumor; however,
no tumor samples were labeled due to the difficulties to
perform this procedure (image perspective, deep location of
the tumor, etc.).
VII. LIMITATIONS
Due to the difficulties to acquire in-vivo HS images during
human neurosurgical procedures, during 2 years we were
only able to capture the most common tumor types that were
available during the surgical procedures in both participant
hospitals (mainly GBM tumors). Since the customized HS
acquisition system is a preliminary demonstrator, the system
has several limitations. One of them is that the system was
only able to capture tumor images where the tumor was
either on the surface or in a deeper layer, but easy enough
to be focused and captured. Moreover, the HS pushbroom
camera employed for the demonstrator development requires
to perform a spatial scanning, considerably increasing the
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TABLE 1. Summary of the in-vivo HS human brain image database.
acquisition time of the HS image. The inherit movement
of the undergoing patient’s brain and also the possible arti-
facts, which can appear in the image (such as extravasated
blood or surgical serum) during the acquisition, can affect
the spatial coherence of the image. In this sense, snapshot
cameras (HS cameras that are able to acquire both the spatial
and spectral features of a scene in a single shot) are the
most suitable option for this application, achieving real-time
image acquisition. However, the number of spectral bands in
these cameras is extremely lower compared to pushbroom
cameras (∼10 times less). Therefore, further investigations
must be performed by using HS images captured with push-
broom cameras (with high spectral resolution) in order to
identify the most relevant bands that allow the identification
and delineation of brain tumors. These results will provide
valuable feedback to snapshot camera manufacturers that will
be able to develop specific HS sensors for this particular
application.
Due to the limited availability of patients, it is an extremely
hard task to achieve a comprehensive database that covers
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FIGURE 12. RGB representations of the HS images that compose the
in-vivo HS human brain image database. The numeric code shown above
each image represents the Patient ID and Image ID (PatientID-ImageID)
that are detailed in Table 1. Yellow lines surround the approximate tumor
area identified by the neurosurgeon experience and the indications of the
IGS system.
the entire heterogeneity that could be found across the dif-
ferent patients and the different types of brain tumors. For
this reason, in this paper we present a preliminary database
that can be employed to perform further investigations in
the use of HSI to: 1) identify the different tissue and tumor
types; 2) delineate the boundaries of the tumors, parenchyma,
blood vessels or other regions of interest for the neuro-
surgeons; 3) provide other kind of information to the sur-
geons that can be useful to improve the outcomes of the
surgery.
The methodology presented in this paper to generate a
labeled dataset that can be used for training supervised clas-
sifiers, mainly exploits the spectral characteristics of HSI to
differentiate between the different types of tissues. Intraoper-
ative MRI and the knowledge and experience of the surgeons
that participated in the project were employed as a guidance
tool to identify the suitable areas to be labeled in the images.
In addition, the pathological analysis results of the tumor
tissue resected during the surgical procedures were employed
to accurately identify the tumor areas and type. In future
data acquisition campaigns, it is expected that more types of
tumors will be included in the database with a more detailed
pathological description.
Moreover, further investigations should be done in order
to properly correlate the biological properties of the different
brain tissue types (especially of the different types of tumors
and normal tissues) with the spectral responses obtained by
the HS cameras at each wavelength. This study could help
in the better discrimination of the different types of tissues,
providing better outcomes in the delineation and identifi-
cation of the tumors, especially in the surrounding normal
tissue infiltrated by the tumor. Specific studies should be done
to determine these differences and provide a more detailed
labeled dataset. Although the labeled dataset presented in
this work was obtained conservatively (we tried to label
only the pixels where the experts were highly confident that
belonged to a certain class) using the methodology based
on the combination between the SAM algorithm and the
pathological analysis, a new detailed labeled dataset could be
used to validate it. In addition, other types of neurosurgical
procedures not involving brain tumor should be included in
further data campaigns in order to obtain a higher number of
normal tissue samples, ensuring that they are not affected by
the infiltrated tumor.
VIII. CONCLUSIONS
The work performed during the execution of the HELICoiD
European project, developing an intraoperative system capa-
ble of acquiring HS images during neurosurgery proce-
dures, allows giving to the international scientific commu-
nity open access to the first public in-vivo hyperspectral
human brain image database specifically for brain can-
cer detection. We believe that the public access of this
database could promote advances in the field of in-vivo
brain research based on hyperspectral imaging, not only
for brain cancer research but also for other brain prob-
lems such as tissue oxygenation identification, hemoglobin
peaks identification in the spectral signatures, parenchymal
area identification, brain vascularization map generation,
etc.
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The HS acquisition system was assessed during surgical
procedures in two different hospitals in the UK and Spain,
obtaining 36 images from 22 different patients in the VNIR
spectral range (between 400 and 1000 nm). The obtained
HS images were labeled by specialists (neurosurgeons) in
order to offer a highly reliable four-classes labeled dataset,
where it was possible to distinguish between normal brain
tissue, brain tissue affected by cancer (both primary and
secondary), blood vessels and background elements. In this
paper, the repeatability experiments (both spectral and spa-
tial) performed to the HS acquisition system in order to assess
the quality of the obtained data have been presented. In addi-
tion, this repeatability analysis revealed that the suitable
spectral range where the system can operate more efficiently
is comprised between 450 and 900 nm. This database has
been successfully employed to generate classification maps
where the tumor boundaries are identified and delineated by
using traditional machine learning techniques [32], [52] and
also deep learning approaches [53], [54]. In addition, it has
been employed as input images for the acceleration of these
HSI processing algorithms obtaining processing surgical-
time results that range between 15 to 70 seconds, depending
on the employed platform for the acceleration [55]–[60]. All
the HS image files generated from this study are available
from: http://hsibraindatabase.iuma.ulpgc.es.
REFERENCES
[1] G. Lu and B. Fei, ‘‘Medical hyperspectral imaging: A review,’’ Proc. SPIE,
vol. 19, no. 1, 2014, Art. no. 010901.
[2] C. Starr, C. A. Evers, and L. Starr, Biology: Concepts and Applications
Without Physiology. Boston, MA, USA: Cengage Learning, 2010.
[3] T. Adão et al., ‘‘Hyperspectral imaging: A review on UAV-based sensors,
data processing and applications for agriculture and forestry,’’ Remote
Sens., vol. 9, no. 11, p. 1110, 2017.
[4] M. Govender, K. Chetty, and H. Bulcock, ‘‘A review of hyperspectral
remote sensing and its application in vegetation and water resource stud-
ies,’’ Water SA, vol. 33, no. 2, pp. 145–152, 2007.
[5] G. Cano et al., ‘‘Automatic selection of molecular descriptors using ran-
dom forest: Application to drug discovery,’’ Expert Syst. Appl., vol. 72,
pp. 151–159, Apr. 2017.
[6] T. Puchert, D. Lochmann, J. C. Menezes, and G. Reich, ‘‘Near-infrared
chemical imaging (NIR-CI) for counterfeit drug identification—A four-
stage concept with a novel approach of data processing (Linear Image
Signature),’’ J. Pharmaceutical Biomed. Anal., vol. 51, no. 1, pp. 138–145,
2010.
[7] Y.-Z. Feng and D.-W. Sun, ‘‘Application of hyperspectral imaging in food
safety inspection and control: A review,’’ Crit. Rev. Food Sci. Nutrition,
vol. 52, no. 11, pp. 1039–1058, 2012.
[8] A. A. Gowen, C. P. O’Donnell, P. J. Cullen, G. Downey, and J. Frias,
‘‘Hyperspectral imaging—An emerging process analytical tool for food
quality and safety control,’’ Trends Food Sci. Technol., vol. 18, no. 12,
pp. 590–598, 2007.
[9] D. Wu and D.-W. Sun, ‘‘Advanced applications of hyperspectral imag-
ing technology for food quality and safety analysis and assessment:
A review—Part I: Fundamentals,’’ Innov. Food Sci. Emerg. Technol.,
vol. 19, pp. 1–14, Jul. 2013.
[10] D. Lorente, N. Aleixos, J. Gómez-Sanchis, S. Cubero,
O. L. García-Navarrete, and J. Blasco, ‘‘Recent advances and applications
of hyperspectral imaging for fruit and vegetable quality assessment,’’
Food Bioprocess Technol., vol. 5, no. 4, pp. 1121–1142, Nov. 2011.
[11] Y. Montembeault, P. Lagueux, V. Farley, A. Villemaire, and K. C. Gross,
‘‘Hyper-Cam:Hyperspectral IR imaging applications in defence innovative
research,’’ in Proc. 2nd Workshop Hyperspectral Image Signal Process.,
Evol. Remote Sens., 2010, pp. 1–4.
[12] P. W. Yuen and M. Richardson, ‘‘An introduction to hyperspectral imaging
and its application for security, surveillance and target acquisition,’’ Imag.
Sci. J., vol. 58, no. 5, pp. 241–253, 2010.
[13] M. A. Calin, S. V. Parasca, D. Savastru, and D. Manea, ‘‘Hyperspectral
imaging in the medical field: Present and future,’’ Appl. Spectrosc. Rev.,
vol. 49, no. 6, pp. 435–447, 2014.
[14] D. Hanahan and R. A. Weinberg, ‘‘Hallmarks of cancer: The next genera-
tion,’’ Cell, vol. 144, no. 5, pp. 646–674, 2011.
[15] M. F. Parker, J. P. Karins, and D. M. O’Connor, ‘‘Hyperspectral diagnostic
imaging of the cervix: Initial observations,’’ in Proc. Med. Technol. Symp.,
1998, pp. 144–148.
[16] Y. Hou, Z. Ren, G. Liu, L. Zeng, and Z. Huang, ‘‘Design of a novel
LD-induced hyper-spectral imager for breast cancer diagnosis based on
VHT grating,’’ in Proc. Symp. Photon. Optoelectron. (SOPO), 2011,
pp. 1–4.
[17] B. Kim, N. Kehtarnavaz, P. LeBoulluec, H. Liu, Y. Peng, and D. Euhus,
‘‘Automation of ROI extraction in hyperspectral breast images,’’ in
Proc. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. (EMBC), Jul. 2013,
pp. 3658–3661.
[18] R. Pourreza-Shahri, F. Saki, N. Kehtarnavaz, P. Leboulluec, and H. Liu,
‘‘Classification of ex-vivo breast cancer positive margins measured by
hyperspectral imaging,’’ in Proc. IEEE Int. Conf. Image Process. (ICIP),
Sep. 2013, pp. 1408–1412.
[19] Z. Han, A. Zhang, X. Wang, Z. Sun, M. D. Wang, and T. Xie, ‘‘In vivo
use of hyperspectral imaging to develop a noncontact endoscopic diagnosis
support system formalignant colorectal tumors,’’Proc. SPIE, vol. 21, no. 1,
2016, Art. no. 016001.
[20] K. Masood and N. Rajpoot, ‘‘Texture based classification of hyperspectral
colon biopsy samples using CLBP,’’ in Proc. IEEE Int. Symp. Biomed.
Imag., Nano Macro, Jun./Jul. 2009, pp. 1011–1014.
[21] K. Masood, N. Rajpoot, K. Rajpoot, and H. Qureshi, ‘‘Hyperspectral colon
tissue classification using morphological analysis,’’ in Proc. Int. Conf.
Emerg. Technol., 2006, pp. 735–741.
[22] K. M. Rajpoot and N. M. Rajpoot, ‘‘Wavelet based segmentation of hyper-
spectral colon tissue imagery,’’ in Proc. IEEE 7th Int. Multi Topic Conf.
(INMIC), Dec. 2003, pp. 38–43.
[23] H. Akbari, Y. Kosugi, K. Kojima, and N. Tanaka, ‘‘Detection and anal-
ysis of the intestinal ischemia using visible and invisible hyperspectral
imaging,’’ IEEE Trans. Biomed. Eng., vol. 57, no. 8, pp. 2011–2017,
Aug. 2010.
[24] D. T. Dicker et al., ‘‘Differentiation of normal skin and melanoma using
high resolution hyperspectral imaging,’’ Cancer Biol. Ther., vol. 5, no. 8,
pp. 1033–1038, 2016.
[25] S. Gaudi et al., ‘‘Hyperspectral imaging of melanocytic lesions,’’ Amer. J.
Dermatopathol., vol. 36, no. 2, pp. 131–136, 2014.
[26] H. Akbari, L. V. Halig, H. Zhang, D. Wang, Z. G. Chen, and B. Fei,
‘‘Detection of cancer metastasis using a novel macroscopic hyperspectral
method,’’ Proc. SPIE, vol. 8317, Apr. 2012, Art. no. 831711.
[27] B. Fei, H. Akbari, and L. V. Halig, ‘‘Hyperspectral imaging and spectral-
spatial classification for cancer detection,’’ in Proc. 5th Int. Conf. Biomed.
Eng. Inform. (BMEI), 2012, pp. 62–64.
[28] W. Laffers et al., ‘‘Early recognition of cancerous lesions in the mouth and
oropharynx: Automated evaluation of hyperspectral image stacks,’’ HNO,
vol. 64, no. 1, pp. 27–33, Jan. 2016.
[29] L. Zhi, D. Zhang, J.-Q. Yan, Q.-L. Li, and Q.-L. Tang, ‘‘Classification of
hyperspectral medical tongue images for tongue diagnosis,’’Comput. Med.
Imag. Graph., vol. 31, no. 8, pp. 672–678, Dec. 2007.
[30] Z. Liu, H. Wang, and Q. Li, ‘‘Tongue tumor detection in medical hyper-
spectral images,’’ Sensors, vol. 12, no. 1, pp. 162–174, 2012.
[31] Z. Liu, J.-Q. Yan, D. Zhang, and Q.-L. Li, ‘‘Automated tongue segmen-
tation in hyperspectral images for medicine,’’ Appl. Opt., vol. 46, no. 34,
pp. 8328–8334, 2007.
[32] H. Fabelo et al., ‘‘An intraoperative visualization system using hyperspec-
tral imaging to aid in brain tumor delineation,’’ Sensors, vol. 18, no. 2,
p. 430, 2018.
[33] N. Sanai and M. S. Berger, ‘‘Glioma extent of resection and its
impact on patient outcome,’’ Neurosurgery, vol. 62, no. 4, pp. 753–764,
2008.
[34] S. Kabwama et al., ‘‘Intra-operative hyperspectral imaging for brain
tumour detection and delineation: Current progress on the HELICoid
project,’’ Int. J. Surg., vol. 36, p. S140, Dec. 2016.
[35] I. J. Gerard, M. Kersten-Oertel, K. Petrecca, D. Sirhan, J. A. Hall, and
D. L. Collins, ‘‘Brain shift in neuronavigation of brain tumors: A review,’’
Med. Image Anal., vol. 35, pp. 403–420, Jan. 2017.
VOLUME 7, 2019 39111
H. Fabelo et al.: In-Vivo Hyperspectral Human Brain Image Database for Brain Cancer Detection
[36] R. E. Kast et al., ‘‘Raman molecular imaging of brain frozen tissue sec-
tions,’’ J. Neuro-Oncol., vol. 120, no. 1, pp. 55–62, 2014.
[37] M. H. T. Reinges, H.-H. Nguyen, T. Krings, B.-O. Hütter, V. Rohde, and
J. M. Gilsbach, ‘‘Course of brain shift during microsurgical resection of
supratentorial cerebral lesions: Limits of conventional neuronavigation,’’
Acta Neurochirurgica, vol. 146, no. 4, pp. 369–377, 2004.
[38] C. Nimsky, O. Ganslandt, P. Hastreiter, and R. Fahlbusch, ‘‘Intraoperative
compensation for brain shift,’’ Surg. Neurol., vol. 56, no. 6, pp. 357–364,
2001.
[39] R. U. Gandhe and C. P. Bhave, ‘‘Intraoperative magnetic resonance imag-
ing for neurosurgery—An anaesthesiologist’s challenge,’’ Indian J. Anaes-
thesia, vol. 62, no. 6, pp. 411–417, Jun. 2018.
[40] R. M. Young, A. Jamshidi, G. Davis, and J. H. Sherman, ‘‘Current trends
in the surgical management and treatment of adult glioblastoma,’’ Ann.
Transl. Med., vol. 3, no. 9, p. 121, 2015.
[41] F. Prada et al., ‘‘Intraoperative contrast-enhanced ultrasound for brain
tumor surgery,’’ Neurosurgery, vol. 74, no. 5, pp. 542–552, 2014.
[42] A. G. Chacko, N. K. S. Kumar, G. Chacko, R. Athyal, and V. Rajshekhar,
‘‘Intraoperative ultrasound in determining the extent of resection of
parenchymal brain tumours—A comparative study with computed tomog-
raphy and histopathology,’’ Acta Neurochirurgica, vol. 145, no. 9,
pp. 743–748, 2003.
[43] M. A. Hammoud, B. L. Ligon, R. Elsouki, W. M. Shi, D. F. Schomer, and
R. Sawaya, ‘‘Use of intraoperative ultrasound for localizing tumors and
determining the extent of resection: A comparative study with magnetic
resonance imaging,’’ J. Neurosurgery, vol. 84, no. 5, pp. 737–741, 1996.
[44] A. V. Moiyadi and P. Shetty, ‘‘Direct navigated 3D ultrasound for resection
of brain tumors: A useful tool for intraoperative image guidance,’’ Neuro-
surgical focus, vol. 40, no. 3, p. E5, 2016.
[45] W. Stummer, U. Pichlmeier, T. Meinel, O. D. Wiestler, F. Zanella, and
H. J. Reulen, ‘‘Fluorescence-guided surgery with 5-aminolevulinic acid for
resection of malignant glioma: A randomised controlled multicentre phase
III trial,’’ Lancet Oncol., vol. 7, no. 5, pp. 392–401, 2006.
[46] F. W. Floeth et al., ‘‘Comparison of 18F-FET PET and 5-ALA fluores-
cence in cerebral gliomas,’’ Eur. J. Nucl. Med. Mol. Imag., vol. 38, no. 4,
pp. 731–741, 2011.
[47] S. Ortega, H. Fabelo, R. Camacho, M. L. Plaza, G. M. Callicó, and
R. Sarmiento, ‘Detecting brain tumor in pathological slides using hyper-
spectral imaging,’’ Biomed. Opt. Express, vol. 9, no. 2, 2018.
[48] H. Fabelo et al., ‘‘HELICoiD project: A new use of hyperspectral imaging
for brain cancer detection in real-time during neurosurgical operations,’’
Proc. SPIE, vol. 9860, May 2016, Art. no. 986002.
[49] R. Salvador et al., ‘‘Demo: HELICoiD tool demonstrator for real-time
brain cancer detection,’’ in Proc. Conf. Design Architectures Signal Image
Process. (DASIP), 2016, pp. 237–238.
[50] F. A. Kruse et al., ‘‘The spectral image processing system (SIPS)—
Interactive visualization and analysis of imaging spectrometer data,’’
Remote Sens. Environ., vol. 44, nos. 2–3, pp. 145–163, 1993.
[51] K. Peleg, G. L. Anderson, and C. Yang, ‘‘Repeatability of hyperspectral
imaging systems—Quantification and improvement,’’ Int. J. Remote Sens.,
vol. 26, no. 1, pp. 115–139, 2005.
[52] H. Fabelo et al., ‘‘Spatio-spectral classification of hyperspectral images
for brain cancer detection during surgical operations,’’ PLoS ONE, vol. 13,
no. 3, 2018, Art. no. e0193721.
[53] H. Fabelo et al., ‘‘Surgical aid visualization system for glioblastoma tumor
identification based on deep learning and in-vivo hyperspectral images of
human patients,’’ Proc. SPIE, vol. 10951, p. 35, Mar. 2019.
[54] H. Fabelo et al., ‘‘Deep learning-based framework for in vivo identifica-
tion of glioblastoma tumor using hyperspectral images of human brain,’’
Sensors, vol. 19, no. 4, p. 920, Feb. 2019.
[55] E. Torti et al., ‘‘Acceleration of brain cancer detection algorithms during
surgery procedures using GPUs,’’ Microprocessors Microsyst., vol. 61,
pp. 171–178, Sep. 2018.
[56] R. Lazcano et al., ‘‘Adaptation of an iterative PCA to a manycore architec-
ture for hyperspectral image processing,’’ J. Signal Process. Syst., pp. 1–13,
May 2018.
[57] D. Madroñal et al., ‘‘SVM-based real-time hyperspectral image classifier
on a manycore architecture,’’ J. Syst. Archit., vol. 80, pp. 30–40, Oct. 2017.
[58] A. Hernández, H. Fabelo, S. Ortega, A. Báez, G. M. Callicó, and
R. Sarmiento, ‘‘Random forest training stage acceleration using graphics
processing units,’’ inProc. 32nd Conf. Design Circuits Integr. Syst. (DCIS),
2017, pp. 1–6.
[59] G. Florimbi et al., ‘‘Accelerating the K-nearest neighbors filtering algo-
rithm to optimize the real-time classification of human brain tumor in
hyperspectral images,’’ Sensors, vol. 18, no. 7, p. 2314, Jul. 2018.
[60] E. Torti et al., ‘‘Parallel K-means clustering for brain cancer detection using
hyperspectral images,’’ Electronics, vol. 7, no. 11, p. 283, Oct. 2018.
HIMAR FABELO received the degree in telecom-
munication engineering and the master’s degree in
telecommunication technologies from the Univer-
sity of Las Palmas de Gran Canaria, Las Palmas de
Gran Canaria, Spain, in 2013, and 2014, respec-
tively. Since 2014, he has been conducting his
research activity in the Integrated System Design
Division, Institute for Applied Microelectronics,
University of Las Palmas de Gran Canaria, in elec-
tronic and bioengineering. In 2015, he started to
work as a Coordination Assistant and a Researcher with the HELICoiD
European Project, co-funded by the European Commission. In 2018, he per-
forms a research stay in the Department of Bioengineering, Erik Jonsson
School of Engineering and Computer Science, The University of Texas at
Dallas, collaborating with Prof. B. Fei in the use of medical hyperspectral
imaging analysis using deep learning. His research interests include the use
of machine learning and deep learning techniques applied to hyperspectral
images to discriminate between healthy and tumor samples for human brain
tissues in real time during neurosurgical operations.
SAMUEL ORTEGA received the degree in
telecommunication engineering and the master’s
(research) degree in telecommunication technolo-
gies from the University of Las Palmas de Gran
Canaria, Spain, in 2014, and 2015, respectively.
Since 2015, he has been conducting his research
activity in the Integrated System Design Division,
Institute for Applied Microelectronics, University
of Las Palmas de Gran Canaria, in electronic and
bioengineering. In 2015, he started to work as a
Coordination Assistant and a Researcher with the HELICoiD European
Project, co-funded by the European Commission. His current research inter-
est includes the use of machine learning algorithms in medical applications
using hyperspectral images.
ADAM SZOLNA received the M.D. and Ph.D.
degrees from the Medical University of Lodz,
Poland, in 1998 and 2005, respectively, as a result
of a five year clinical study conducted on the
patients operated for dystonia. He is currently a
Specialist in neurosurgery. He is also a member of
the permanent staff of the Neurosurgery Depart-
ment, University Hospital Doctor Negrin, Las Pal-
mas de Gran Canaria. He has co-authored a book
Functional Neurosurgery. His current research
interests include hyperspectral imaging and real-time intraoperative brain
tumour detection, participating in the HELICOID Project as a Princi-
pal Investigator. He is a member of the Spanish Society of Neurosur-
geons, the European Society for Stereotactic and Functional Neurosurgery,
the Section of Stereotaxy and Functional Neurosurgery, Polish Society of
Neurosurgeons, and the Polish Society of Neurosurgeons. He was serving
16 years for Military Health Service, Poland, and NATO, up to the rank of
major.
39112 VOLUME 7, 2019
H. Fabelo et al.: In-Vivo Hyperspectral Human Brain Image Database for Brain Cancer Detection
DIEDERIK BULTERS is currently a Consultant
Neurosurgeon and an Honorary Senior Clinical
Lecturer with the University of Southampton
and trained in Edinburgh, Southampton, and
Cambridge. The team received grants from
EPSRC, TSB, NIHR, EU, and Wessex Med-
ical Research. His current research interests
include neurovascular disease, neurotrauma, and
neuro-oncology.
JUAN F. PIÑEIRO received the M.D. degree from
the High Institute of Medical Sciences of Villa
Clara, Cuba, in 1993. He is currently a Special-
ist in neurosurgery. He is also the former Head
of the Neurosurgical Department, Dr. Gustavo
Aldereguia Hospital, Cienfuegos, Cuba. He is also
a Specialist in neurosurgery with University Hos-
pital Doctor Negrin, Las Palmas de Gran Canaria,
and also with Vithas Santa Catalina Hospital, Las
Palmas de Gran Canaria. He has authored a book
chapter and several papers and contributions to technical conferences. His
research interests include head trauma, neurovascular surgery, and the appli-
cation of new technologies for oncological Neurosurgery. He is a mem-
ber of the Spanish Society of Neurosurgery, the Cuban Society of Neu-
rology and Neurosurgery, and the European Association of Neurological
Surgeons.
SILVESTER KABWAMA is currently a Neuro-
surgery Research Fellow with the Wessex Neu-
rological Centre. He trained at the University of
Southampton and King’s College London. He is
responsible for the day to day running of the HELI-
CoiD Project at the Wessex Neurological Centre.
His research interests include the development and
management of brain tumours.
ARUMA J-O’SHANAHAN is currently pursuing
the Ph.D. degree with the University of La Laguna,
Tenerife, Spain. She received the training with a
fellowship in vascular neurosurgery with the Uni-
versity Hospital of Helsinki, Finland, along with
observerships at Teishinkai Hospital, Japan, and
also with Toronto Western Hospital, Canada. She
is currently a Specialist in neurosurgery. She is also
a member of the Staff of the Neurosurgery Depart-
ment, the University Hospital Doctor Negrin, Las
Palmas de Gran Canaria, where she is actually a part of the Neuro Inter-
ventionist Radiology Team. Her current research interests include vascular
neurosurgery. She is a member of the College of Physicians of Las Palmas
de Gran Canaria, the Spanish Society of Neurosurgeons, and the European
Society of Neurosurgery.
HARRY BULSTRODE is currently a Neurosurgery
Registrar and a Wellcome Research Training Fel-
low. He has trained in Cambridge, Oxford, Lon-
don, Southampton, and Edinburgh. His research
interests include molecular biology of neural stem
cells and brain tumours, and to the application of
spectral analysis to guide brain tumour resection.
SARA BISSHOPP received the M.D. degree from
the Medicine High School, La Laguna Univer-
sity, Spain, in 2009, and the Honors degree. She
has performed a 3- month’s rotation internship in
the Pediatrics Unit of Hospital Virgen del Rocio,
Seville. She received the training in spine surgery
with a 3-months rotation internship in the Spine
Unit, Virgen del Rocío Hospital. Because of her
interest in oncological Neurosurgical research, she
has participated in the HELICOID Project as a Co-
Investigator. She is currently a Specialist in neurosurgery. She is also a
member of the Staff of the Neurosurgery Department, University Hospital
Doctor Negrin, Las Palmas de Gran Canaria. She is a member of the Spanish
Society of Neurosurgery and the European Society of Neurosurgery.
B. RAVI KIRAN received the Ph.D. degree from
University Paris-Est, in 2014 on optimization over
energetic lattices for image segmentation. He was
a Postdoctoral Researcher with the CAOR Lab,
Mines ParisTech, in 2015, on hyperspectral image
processing for tumor delineation, on which he con-
tinues to collaborate with the Helicoid team to
this day. He was also a Postdoctoral Researcher
with the DATA lab, ENS Paris, in 2016, on unsu-
pervised streaming time series anomaly detection.
He was a temporary Assistant Professor and a Research with University
Lille 3, from 2016 to 2017, during which he primarily taught machine
learning and data mining. Since 2018, he has been a Research Engineer
with Autonomous Systems, AKKA Technologies, where he works on deep
reinforcement learning for autonomous driving.
DANIELE RAVÌ received the master’s degree
(summa cum laude) in computer science from
the University of Catania, in 2007, and the Ph.D.
degree with the Department of Mathematics and
Computer Science, University of Catania, Italy,
in 2014. From 2008 to 2010, hewaswith STMicro-
electronics (Advanced System Technology Imag-
ingGroup) as a Consultant. Hewaswith the Centre
for Vision, Speech and Signal Processing, Univer-
sity of Surrey, U.K. Since 2014, he has been a
Research Associate with the Hamlyn Centre for Robotic Surgery, Imperial
College London, for almost four years. He is currently a Senior Research
Associate in computer vision, machine learning, image-guided surgery and
smart sensing with the Wellcome/EPSRC Centre Interventional and Surgical
Sciences, University College of London. He has contributed to several
research projects funded by the EU and the industry. He has co-authored
different papers including book chapters, international journals, and interna-
tional conference proceedings.
VOLUME 7, 2019 39113
H. Fabelo et al.: In-Vivo Hyperspectral Human Brain Image Database for Brain Cancer Detection
RAQUEL LAZCANO received the B.Sc. degree
in communication electronics engineering and the
M.Sc. degree in systems and services engineering
for the information society from the Universidad
Politécnica de Madrid, Spain, in 2014 and 2015,
respectively, where she is currently pursuing the
Ph.D. degree in systems and services engineering
for the information society with the Electronic
and Microelectronic Design Group. In 2015, she
stayed four months at the Institute of Electronics
and Telecommunications of Rennes (IETR), National Institute of Applied
Sciences (INSA), France, as an Interchange Student of the M.Sc. degree.
She has authored or co-authored five indexed journals and 16 contributions
to technical conferences. Her research interests include high-performance
multicore processing systems, real-time hyperspectral image processing, and
the automatic optimization of the parallelism in real-time systems.
DANIEL MADROÑAL received the B.Sc. degree
in communication electronics engineering and the
M.Sc. degree in systems and services engineering
for the information society from the Universidad
Politécnica de Madrid, Spain, in 2014 and 2015,
respectively, where he is currently pursuing the
Ph.D. degree in systems and services engineering
for the information society with the Electronic and
Microelectronic Design Group (GDEM). In 2015,
he stayed 4 months at the National Institute of
Applied Sciences (INSA), France, as an Interchange Student of the M.Sc.
degree. He has authored or co-authored five indexed journals and 16 con-
tributions to technical conferences. His research interests include high-
performance multicore processing systems, real-time hyperspectral image
processing, and the automatic optimization of the energy consumption in
high-performance systems.
CORALIA SOSA received the M.D. and Ph.D.
degrees from the Medical Faculty, University of
Las Palmas de Gran Canaria, in 2007 and 2016,
respectively, as a result of a clinical study on the
patients subaracnoid haemorrhage in poor grade
neurological status. She is currently a Specialist in
neurosurgery. She is also a member of the Staff of
the Neurosurgery Department, University Hospi-
tal Doctor Negrin, Las Palmas de Gran Canaria.
She trained for four months at the Addembrooke
Hospital, Cambridge, in brain cancer surgery. Her current research interests
include hyperspectral imaging and real-time intraoperative brain tumour
detection, participating in the HELICOID project as a Principal Investigator.
She is a member of Spanish and European Society of Neurosurgeons.
CARLOS ESPINO is currently a Specialist in neu-
rosurgery. He is also a member of the permanent
staff of the Neurosurgery Department, Univer-
sity Hospital Doctor Negrin, Las Palmas de Gran
Canaria.
MARIANO MARQUEZ is currently a Special-
ist in neurosurgery. He is also a member of the
permanent staff of the Neurosurgery Department,
University Hospital Doctor Negrin, Las Palmas de
Gran Canaria.
MARÍA DE LA LUZ PLAZA received the Ph.D.
degree by ULPGC, in 2002, where she is cur-
rently Associate Professor of histopathology with
the Faculty of Medicine. She is also a Spe-
cialist in histopathology with the Department
of Histopathology, University Hospital Doctor
Negrin, Las Palmas de Gran Canaria. She is a
member of the Spanish Society of Pathologic
Anatomy.
RAFAEL CAMACHO is currently a Specialist in
pathology. He is also the former Head of the
Pathology Department, University Hospital Doc-
tor Negrin, Las Palmas de Gran Canaria, where
he is also a General Pathologist and especially
as a Nephropathologist. He is also the Head of
the Department of Electron Microscopy, Pathol-
ogy Department. He is a member of the Euro-
pean Nephropatology Working Group, College of
Physicians of Las Palmas, and the Spanish Society
of Pathologists.
DAVID CARRERA graduated from theUniversidadAutónoma de Barcelona,
Barcelona, in 2006. After completing neurology training at the Neurol-
ogy Department, Hospital Universitario Germans Trias i Pujol, Badalona,
in 2011, he undertook an observership at the Neurocritical Care Unit,
Columbia University Medical Center, New York, and, after, a fellowship at
the Stroke Unit, Hospital de la Santa Creu i Sant Pau, Barcelona. In 2014,
he started his neurosurgery training, and he is in the fourth year of the
residency program. He is currently a Neurosurgery Trainee with the Neu-
rosurgery Department, University Hospital Doctor Negrin, Las Palmas de
Gran Canaria. He has published peer-reviewed articles in both national and
international journals.
MARÍA HERNÁNDEZ is currently a Medical
Trainee in neurosurgery. After finishing her fifth
and last year of training, she is currently with
the Department of Neurosurgery, Hospital Univer-
sity Hospital Doctor Negrin. She has performed
a 3-months rotation internship in the Pediatric
Unit, Hospital Virgen del Rocío, Seville. She is
currently performing a 2-months observership in
the Neurooncology Unit, Addenbrookes Hospital,
University of Cambridge. She is also a member of
the Spanish Society of Neurosurgery.
39114 VOLUME 7, 2019
H. Fabelo et al.: In-Vivo Hyperspectral Human Brain Image Database for Brain Cancer Detection
GUSTAVO M. CALLICÓ (M’08) received the
M.S. degree (Hons.) in telecommunication engi-
neering and the Ph.D. and European Doctorate
degrees (Hons.) from the University of Las Palmas
de Gran Canaria, in 1995 and 2003, respectively.
From 1996 to 1997, he was granted with a research
grant from the National Educational Ministry and,
in 1997, he was hired by the university as an
Electronic Lecturer. In 1994, he joined the Institute
for Applied Microelectronics (IUMA) and, from
2000 to 2001, he stayed at Philips Research Laboratories, Eindhoven, The
Netherlands, as a Visiting Scientist, where he developed his Ph.D. thesis.
He currently develops his research activities in the Integrated SystemsDesign
Division, IUMA. He is currently an Associate Professor with ULPGC.
Since 2015, he has been responsible for the scientific-technological equip-
ment project called Hyperspectral image acquisition system of high spa-
tial and spectral definition, granted by the General Directorate of research
and management of the National R&D Plan, funded through the General
Directorate of Scientific Infrastructure. He has been the Coordinator of the
European Project HELICoiD (FET, Future, and Emerging Technologies)
under the Seventh Framework Program. He has more than 110 publications
in national and international journals, conferences, and book chapters. He has
participated in 18 research projects funded by the European Community,
the Spanish Government, and international private industries. His current
research interests include hyperspectral imaging for real-time cancer detec-
tion, real-time super-resolution algorithms, synthesis-based design for SOCs
and circuits for multimedia processing and video coding standards, espe-
cially for H.264 and SVC. He has been an Associate Editor of the IEEE
TRANSACTIONS ON CONSUMER ELECTRONICS, since 2009, where he is currently a
Senior Associate Editor. He has been anAssociate Editor of the IEEEACCESS,
since 2016.
JESÚS MORERA MOLINA received the master’s
degree in healthcare management from the Uni-
versity of Pompeu Fabra. He has been the Deputy
Director of the University Hospital Doctor Negrin,
and amember of the Board of the College of Physi-
cians of Las Palmas and of the National Commis-
sion on Neurosurgery. He is currently a Specialist
in neurosurgery. He is currently the Head of neu-
rosurgery with University Hospital Doctor Negrin,
Las Palmas de Gran Canaria, and also a Lecturer
with the University of Las Palmas de Gran Canaria. He is a member of the
Parliament of the Canary Islands.
BOGDAN STANCIULESCU received the B.Sc.
degree in applied physics and the M.Sc. degree
in electronics from the University of Bucharest,
and the Ph.D. thesis in computer vision. His thesis
is on extracting physical models from the image
analysis and synthesis co-evolution from the Ecole
Nationale Supérieure de Techniques Avancées de
Paris, France. He is currently a Senior Researcher
with ARMINES. He is also a Researcher with
the Robotics Laboratory, with a special focusing
on the image analysis for object and pattern recognition. He is also the
Coordinator of a number of national and industrial research projects and
he will be the person in charge for research and technological aspects for
ARMINES for HELICoiD. His research interests include computer vision
and pattern recognition, machine learning for image classification, and
stochastic algorithms.
GUANG-ZHONG YANG (F’11) received the
Ph.D. degree in computer science from Imperial
College London, in 1991. He is currently the
Director and the Co-Founder of The Hamlyn Cen-
tre for Robotic Surgery. He is also the Chairman
of the UK-RAS Network. The mission of the UK-
RAS Network is to provide academic leadership
in RAS, expand collaboration with industry and
integrate and coordinate activities of the EPSRC
funded RAS capital facilities, Centres for Doctoral
Training and partner universities across theUK.His current research interests
include medical imaging, sensing, and robotics.
Prof. Yang is a Fellow of the Royal Academy of Engineering, IET,
AIMBE, IAMBE, MICCAI, and CGI. He was a recipient of the Royal
Society Research Merit Award and listed in The Times Eureka Top 100 in
British Science. He was also a recipient of the CBE in the Queen’s 2017 New
Year Honour for his contribution to biomedical engineering.
RUBÉN SALVADOR received the M.Sc. degree
in 2007 and the Ph.D. degree in industrial electron-
ics from the Universidad Politécnica de Madrid
(UPM), in 2015, where he is currently an Assis-
tant Professor with the Department of Telemat-
ics and Electronics Engineering and a Researcher
Associate with the Center on Software Technolo-
gies and Multimedia Systems for Sustainability
(CITSEM-UPM).
He was a Research Assistant with the Center of
Industrial Electronics, UPM, from 2006 to 2011, and also with the Intelligent
Vehicle Systems Division, University Institute for Automobile Research
(INSIA), UPM, from 2005 to 2006. In 2009, he was a Visiting Research
Student for 4 months with the Department of Computer Systems, Brno
University of Technology. In 2017, he was a Visiting Professor for 5 months
with IETR/INSA, Rennes. He has authored or co-authored around 40 peer
reviewed publications in international journals/conferences and one book
chapter. He has participated in nine EU/national research projects and nine
industrial projects. His research interests include embedded, reconfigurable,
and heterogeneous systems for parallel computing in FPGAs and manycore
accelerators, system self-adaptation, and evolvable hardware. He focuses in
design methodologies and architectures for highly parallel accelerators in
embedded and high performance computing systems in the biomedical and
space fields. The application domain spans hyperspectral image processing,
machine learning, and evolutionary computing techniques for diagnostic
imaging and self-adaptation in harsh environments.
He serves as a TPC member for various international conferences. He acts
as a Reviewer in a number of international journals/conferences.
EDUARDO JUÁREZ (M’96) received the Inge-
niero de Telecomunicación degree from the Uni-
versidad Politécnica de Madrid (UPM), Madrid,
Spain, in 1993, and the Docteur ès Sciences
Techniques degree from the École Polytech-
nique Fédéral de Lausanne (EPFL), Switzerland,
in 2003. In 1994, he joined the Digital Architecture
Group (GAD), UPM, as a Researcher. In 1998,
he joined the Integrated Systems Laboratory (LSI),
EPFL, as an Assistant. In 2000, he joined Tran-
switch Corp., Switzerland, as a Senior System Engineer. In 2004, he joined
the Electronic andMicroelectronic Design Group (GDEM) as a Postdoctoral
Researcher. Since 2013, he has been a Researcher with the Research Centre
of Software Technologies and Multimedia Systems (CITSEM). His current
interests include low power hyperspectral embedded imaging systems for
health applications.
VOLUME 7, 2019 39115
H. Fabelo et al.: In-Vivo Hyperspectral Human Brain Image Database for Brain Cancer Detection
CÉSAR SANZ (S’87–M’88–SM’13) received the
Ingeniero de Telecomunicación degree and the
Doctor Ingeniero de Telecomunicación degree
from the Universidad Politécnica de Madrid,
Spain, in 1989 and 1998, respectively. Since
2008, he has been the Director of the E.U.I.T.
de Telecomunicación, where he currently leads
the Electronic and Microelectronic Design
Group (GDEM) involved in R&D projects with
Spanish and European companies and public insti-
tutions. His interests includemicroelectronic design applied to image coding,
digital TV, digital video broadcasting, and hyperspectral imaging.
ROBERTO SARMIENTO was the Dean of the
Faculty with the Telecommunication Engineering
School, from 1994 to 1995 and a Vice Chancellor
for Academic Affairs and a Staff with ULPGC,
from 1998 to 2003. In 1993, he was a Visiting
Professor with The University of Adelaida, South
Australia, and later at the University of Edith
Cowan, Australia. He is currently a Full Professor
with the Telecommunication Engineering School,
University of Las Palmas de Gran Canaria, Spain,
in electronic engineering. He is also a Founder of the Research Institute
for Applied Microelectronics (IUMA), where he is also the Director of the
Integrated Systems Design Division. Since 1990, he has been publishing
more than 50 journal papers and book chapters and more than 140 confer-
ence papers. He has been awarded with four six years research periods by
the National Agency for the Research Activity Evaluation, Spain. He has
participated in more than 45 projects and research programmes funded by
public and private organizations, from which he has been leader researcher
in 16 of them. Between these projects, it has special mention those funded
by the European Union like GARDEN and the GRASS workgroup and the
funded by the European Spatial Agency TRPAO8032. He has gotten several
agreements with companies for the design of high performance integrated
circuits, where the most important are those performed with Vitesse Semi-
conductor Corporation, California, Ensilica Ltd., U.K., and Thales Alenia
Space, Spain.
39116 VOLUME 7, 2019
